These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21301321

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [Abstract] [Full Text] [Related]

  • 23. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C.
    Int J Cancer; 2002 Jun 01; 99(4):538-48. PubMed ID: 11992543
    [Abstract] [Full Text] [Related]

  • 24. Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2.
    Palayoor ST, Arayankalayil MJ, Shoaibi A, Coleman CN.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6980-6. PubMed ID: 16203791
    [Abstract] [Full Text] [Related]

  • 25. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
    Mukhopadhyay P, Ali MA, Nandi A, Carreon P, Choy H, Saha D.
    Cancer Res; 2006 Feb 01; 66(3):1758-66. PubMed ID: 16452236
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, Lin JT.
    J Biomed Sci; 2005 Feb 01; 12(1):229-41. PubMed ID: 15864753
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
    Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ.
    Cancer Res; 2006 Nov 15; 66(22):10833-42. PubMed ID: 17108119
    [Abstract] [Full Text] [Related]

  • 29. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA.
    Laryngoscope; 2015 Mar 15; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [Abstract] [Full Text] [Related]

  • 30. Epidermal growth factor-induced COX-2 regulates metastasis of head and neck squamous cell carcinoma through upregulation of angiopoietin-like 4.
    Chiang KH, Shieh JM, Shen CJ, Chang TW, Wu PT, Hsu JY, Tsai JP, Chang WC, Chen BK.
    Cancer Sci; 2020 Jun 15; 111(6):2004-2015. PubMed ID: 32227417
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 33. PGE2 production in oral cancer cell lines is COX-2-dependent.
    Husvik C, Khuu C, Bryne M, Halstensen TS.
    J Dent Res; 2009 Feb 15; 88(2):164-9. PubMed ID: 19278989
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma.
    Ko SH, Choi GJ, Lee JH, Han YA, Lim SJ, Kim SH.
    Oncol Rep; 2008 Feb 15; 19(2):425-33. PubMed ID: 18202791
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L, Wu WK, Li ZJ, Liu QC, Li HT, Wu YC, Cho CH.
    Mol Pharmacol; 2009 Jun 15; 75(6):1364-73. PubMed ID: 19264847
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
    Zhang X, Chen ZG, Choe MS, Lin Y, Sun SY, Wieand HS, Shin HJ, Chen A, Khuri FR, Shin DM.
    Clin Cancer Res; 2005 Sep 01; 11(17):6261-9. PubMed ID: 16144930
    [Abstract] [Full Text] [Related]

  • 38. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B.
    J Oral Pathol Med; 2004 Nov 01; 33(10):607-13. PubMed ID: 15482327
    [Abstract] [Full Text] [Related]

  • 39. Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression.
    Jin DZ, Yin LL, Ji XQ, Zhu XZ.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):166-72. PubMed ID: 16989810
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.